KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Short-Term Debt issuances (2018 - 2020)

Cme (CME) has disclosed Short-Term Debt issuances for 4 consecutive years, with -$100.0 million as the latest value for Q2 2020.

  • On a quarterly basis, Short-Term Debt issuances rose 55.12% to -$100.0 million in Q2 2020 year-over-year; TTM through Mar 2021 was -$100.0 million, a 86.83% increase, with the full-year FY2020 number at -$304.6 million, down 229.3% from a year prior.
  • Short-Term Debt issuances was -$100.0 million for Q2 2020 at Cme, up from -$204.6 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $462.3 million in Q1 2019 to a low of -$222.8 million in Q2 2019.
  • A 3-year average of -$1.5 million and a median of -$131.4 million in 2019 define the central range for Short-Term Debt issuances.
  • Biggest YoY gain for Short-Term Debt issuances was 55.12% in 2020; the steepest drop was 144.26% in 2020.
  • Cme's Short-Term Debt issuances stood at $386.9 million in 2018, then plummeted by 133.96% to -$131.4 million in 2019, then rose by 23.9% to -$100.0 million in 2020.
  • Per Business Quant, the three most recent readings for CME's Short-Term Debt issuances are -$100.0 million (Q2 2020), -$204.6 million (Q1 2020), and -$131.4 million (Q4 2019).